MedTrace Logo

Study Comparing Fish Oil and Krill Oil

NCT02670356 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-04-26

No results posted yet for this study

Summary

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are omega-3 fatty acids found in fish oil and in krill oil. The purpose of this study is to compare the effects of the recommended dose of a fish oil supplement (Omax3 4:1 EPA:DHA; recommended daily dose 1650 mg - totaling 1500 mg EPA+DHA) and a krill oil supplement (MegaRed; recommended daily dose 300 mg - totaling 74 mg EPA+DHA) on omega-3 index, plasma biomarkers of inflammation and inflammatory cell activation, and plasma lipid levels in subjects with metabolic syndrome.

Conditions

Interventions

DIETARY_SUPPLEMENT

Fish oil

two 750 mg/capsules/day

DIETARY_SUPPLEMENT

Krill oil

one 300 mg capsule/day

Sponsors & Collaborators

  • Prevention Pharmaceuticals

    collaborator UNKNOWN

  • Tufts University

    lead OTHER

Principal Investigators

  • Stefania Lamon-Fava, Ph.D. · Tufts University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02670356 on ClinicalTrials.gov